Inovio Pharmaceuticals Inc and AbbVie Inc Stock outperforms

The Shares of Inovio Pharmaceuticals Inc. advanced 1.46% to $6.95 Monday. This proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.87% to 14,138.78 and the Dow Jones Industrial Average DJIA falling 0.18% to 33,981.57. The stock’s rise snapped a two-day losing streak.

Inovio Pharmaceuticals Inc. closed $26.84 short of its 52-week high which the company achieved on June 26th. The stock outperformed some of its competitors Monday, as AbbVie Inc. ABBV rose 0.01% to $111.39, Amgen Inc. AMGN fell 0.59% to $255.52, and AstraZeneca PLC ADR AZN rose 0.21% to $52.37. Trading volume (17.2 M) eclipsed its 50-day average volume of 11.8 M

The Shares of AbbVie Inc. inched 0.01% higher to $111.39 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.18% to 4,187.62 and the Dow Jones Industrial Average DJIA falling 0.18% to 33,981.57. This was the stock’s second consecutive day of gains. AbbVie Inc. closed $2.02 short of its 52-week high ($113.41), which the company reached on January 13th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Pfizer Inc. PFE rose 0.05% to $38.68, Eli Lilly & Co. LLY fell 0.79% to $187.22, and AstraZeneca PLC ADR AZN rose 0.21% to $52.37. Trading volume (4.8 M) remained 2.0 million below its 50-day average volume of 6.8 M.